Catheter Precision Inc (AMEX:VTAK)’s traded shares stood at 4.98 million during the last session, with the company’s beta value hitting -0.72. At the close of trading, the stock’s price was $0.30, to imply an increase of 7.90% or $0.02 in intraday trading. The VTAK share’s 52-week high remains $8.40, putting it -2700.0% down since that peak but still an impressive 20.0% since price per share fell to its 52-week low of $0.24. The company has a valuation of $3.32M, with an average of 0.91 million shares in intraday trading volume over the past 10 days and average of 198.43K shares over the past 3 months.
Catheter Precision Inc (AMEX:VTAK) trade information
After registering a 7.90% upside in the last session, Catheter Precision Inc (VTAK) has traded red over the past five days. The 5-day price performance for the stock is 1.34%, and -1.31% over 30 days. With these gigs, the year-to-date price performance is -33.04%. Short interest in Catheter Precision Inc (AMEX:VTAK) saw shorts transact 0.13 million shares and set a 0.61 days time to cover.
VTAK Dividends
Catheter Precision Inc has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Catheter Precision Inc (AMEX:VTAK)’s Major holders
Catheter Precision Inc insiders hold 7.31% of total outstanding shares, with institutional holders owning 5.34% of the shares at 5.76% float percentage. In total, 5.34% institutions holds shares in the company.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Catheter Precision Inc (VTAK) shares. Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 43.62 shares. This is just over 0.40% of the total shares, with a market valuation of $13173.0. Data from the same date shows that the other fund manager holds a little less at 10.59, or 0.10% of the shares, all valued at about 3199.0.
